[HTML][HTML] Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino, A Bonomi… - Cardiovascular …, 2023 - Springer
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
[HTML][HTML] Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino, A Bonomi… - Cardiovascular …, 2023 - ncbi.nlm.nih.gov
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino, A Bonomi… - CARDIOVASCULAR …, 2023 - air.unimi.it
BackgroundGlucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction.
F Trombara, N Cosentino, A Bonomi… - Cardiovascular …, 2023 - search.ebscohost.com
Abstract Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium
glucose cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal …
glucose cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal …
Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction.
F Trombara, N Cosentino, A Bonomi… - Cardiovascular …, 2023 - europepmc.org
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
[HTML][HTML] Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino… - Cardiovascular …, 2023 - cardiab.biomedcentral.com
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2
inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection. Whether their …
inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection. Whether their …
Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino, A Bonomi… - Cardiovascular …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino, A Bonomi… - Cardiovascular …, 2023 - search.proquest.com
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
[PDF][PDF] Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino, A Bonomi, M Ludergnani… - 2023 - cardiab.biomedcentral.com
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
[PDF][PDF] Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction
F Trombara, N Cosentino, A Bonomi, M Ludergnani… - 2023 - air.unimi.it
Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …
cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection …